Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Nonnast-Daniel

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Contributions to Nephrology|January 1, 1989
Hemodynamics in hemodialysis patients treated with recombinant human erythropoietinB Nonnast-Daniel, J Schäffer, U Frei
Klinische Wochenschrift|September 15, 1988
[Erythropoietin and hypertension]U Frei, B Nonnast-Daniel, K M Koch
Clinical Nephrology|July 1, 1992
In vitro production of interleukin-1 from blood mononuclear cells of patients on chronic hemodialysis therapyM Haubitz, B Klöppel, G Lonnemann, et al.
Contributions to Nephrology|January 1, 1991
Hypertension as a possible complication of recombinant human erythropoietin therapyR Brunkhorst, B Nonnast-Daniel, K M Koch, et al.
Contributions to Nephrology|January 1, 1990
Adverse cardiovascular effects of partial correction of renal anemia by recombinant human erythropoietinU Frei, B Nonnast-Daniel, J Schäffer, et al.
American Journal of Cardiac Imaging|April 1, 1995
Evaluation of endocarditis and its complications by biplane and multiplane transesophageal echocardiographyW G Daniel, A Mügge, J Grote, et al.
Nephron|January 1, 1991
Improved physical performance after treatment of renal anemia with recombinant human erythropoietinK M Braumann, B Nonnast-Daniel, D Böning, et al.
The American Journal of Cardiology|October 26, 1999
Pneumatic external counterpulsation: a new noninvasive method to improve organ perfusionD Werner, M Schneider, M Weise, et al.
Blood Purification|January 1, 1990
Two years experience of daily self-administered subcutaneous erythropoietinC Granolleras, B Branger, G Deschodt, et al.
Aktuelle Radiologie|March 1, 1991
[Destructive non-infectious spondylopathy during hemodialysis]B Tekinsoy, B Nonnast-Daniel, J Schäffer, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Contributions to Nephrology|January 1, 1989
Hemodynamics in hemodialysis patients treated with recombinant human erythropoietinB Nonnast-Daniel, J Schäffer, U Frei
Klinische Wochenschrift|September 15, 1988
[Erythropoietin and hypertension]U Frei, B Nonnast-Daniel, K M Koch
Clinical Nephrology|July 1, 1992
In vitro production of interleukin-1 from blood mononuclear cells of patients on chronic hemodialysis therapyM Haubitz, B Klöppel, G Lonnemann, et al.
Contributions to Nephrology|January 1, 1991
Hypertension as a possible complication of recombinant human erythropoietin therapyR Brunkhorst, B Nonnast-Daniel, K M Koch, et al.
Contributions to Nephrology|January 1, 1990
Adverse cardiovascular effects of partial correction of renal anemia by recombinant human erythropoietinU Frei, B Nonnast-Daniel, J Schäffer, et al.
American Journal of Cardiac Imaging|April 1, 1995
Evaluation of endocarditis and its complications by biplane and multiplane transesophageal echocardiographyW G Daniel, A Mügge, J Grote, et al.
Nephron|January 1, 1991
Improved physical performance after treatment of renal anemia with recombinant human erythropoietinK M Braumann, B Nonnast-Daniel, D Böning, et al.
The American Journal of Cardiology|October 26, 1999
Pneumatic external counterpulsation: a new noninvasive method to improve organ perfusionD Werner, M Schneider, M Weise, et al.
Blood Purification|January 1, 1990
Two years experience of daily self-administered subcutaneous erythropoietinC Granolleras, B Branger, G Deschodt, et al.
Aktuelle Radiologie|March 1, 1991
[Destructive non-infectious spondylopathy during hemodialysis]B Tekinsoy, B Nonnast-Daniel, J Schäffer, et al.
Pageof 3